Joel Greenblatt Gilead Sciences, Inc. Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 255,168 shares of GILD stock, worth $23.6 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

255,168

Previous 281,452 9.34%

Holding current value

$23.6 Million

Previous $19.3 Million 10.76%

% of portfolio

0.23%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $1.75 Million - $2.21 Million	-26,284 Reduced 9.34%	255,168 $21.4 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $8.41 Million - $9.7 Million	133,164 Added 89.8%	281,452 $19.3 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $3.78 Million - $4.61 Million	52,866 Added 55.4%	148,288 $10.9 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $6.17 Million - $7 Million	-84,227 Reduced 46.88%	95,422 $7.73 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $5.08 Million - $5.54 Million	68,646 Added 61.84%	179,649 $13.5 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $857,164 - $977,715	11,277 Added 11.31%	111,003 $8.56 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $1.58 Million - $1.8 Million	20,404 Added 25.72%	99,726 $8.27 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $21,500 - $30,867	345 Added 0.44%	79,322 $6.81 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $826,831 - $944,454	-13,887 Reduced 14.95%	78,977 $4.87 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $614,775 - $692,421	-10,651 Reduced 10.29%	92,864 $5.74 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.05 Million - $1.32 Million	18,160 Added 21.28%	103,515 $6.15 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $2.05 Million - $2.33 Million	-31,662 Reduced 27.06%	85,355 $6.2 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $1.64 Million - $1.77 Million	24,187 Added 26.06%	117,017 $8.17 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $603,218 - $659,102	-9,504 Reduced 9.29%	92,830 $6.39 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $2.72 Million - $3.11 Million	-45,359 Reduced 30.71%	102,334 $6.61 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $4.61 Million - $5.26 Million	81,414 Added 122.84%	147,693 $8.61 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $1.55 Million - $1.95 Million	-25,000 Reduced 27.39%	66,279 $4.19 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $4.73 Million - $5.49 Million	-65,368 Reduced 41.73%	91,279 $7.02 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $5.91 Million - $7.57 Million	-94,403 Reduced 37.6%	156,647 $11.7 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $13 Million - $14.4 Million	-211,763 Reduced 45.76%	251,050 $16.3 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $11.2 Million - $12.3 Million	178,621 Added 62.85%	462,813 $29.3 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $2.77 Million - $3.11 Million	44,776 Added 18.7%	284,192 $19.2 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $19.6 Million - $22 Million	-314,073 Reduced 56.74%	239,416 $15.6 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $11.7 Million - $15.3 Million	193,250 Added 53.64%	553,489 $34.6 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $3.99 Million - $4.42 Million	-56,012 Reduced 13.46%	360,239 $27.8 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $7.85 Million - $9.16 Million	-121,051 Reduced 22.53%	416,251 $29.5 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $9.29 Million - $11.3 Million	-127,490 Reduced 19.18%	537,302 $40.5 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $2.26 Million - $2.66 Million	-31,830 Reduced 4.57%	664,792 $47.6 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $50.2 Million - $59.5 Million	696,622	696,622 $56.4 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account